Adriamycin pfs and Tooth abscess - a phase IV clinical study of FDA data
Summary:
Tooth abscess is found among people who take Adriamycin pfs, especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Adriamycin pfs and have Tooth abscess. It is created by eHealthMe based on reports of 6,484 people who have side effects when taking Adriamycin pfs from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
6,484 people reported to have side effects when taking Adriamycin pfs.
Among them, 166 people (2.56%) have Tooth abscess.
What is Adriamycin pfs?
Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users for its effectiveness, alternative drugs and more.
What is Tooth abscess?
Tooth abscess (pus formation in tooth) is found to be associated with 2,420 drugs and 1,597 conditions by eHealthMe.
Number of Adriamycin pfs and Tooth abscess reports submitted per year:
Time on Adriamycin pfs when people have Tooth abscess *:
Gender of people who have Tooth abscess when taking Adriamycin pfs*:
Age of people who have Tooth abscess when taking Adriamycin pfs *:
Common drugs people take besides Adriamycin pfs *:
Common side effects people have besides Tooth abscess *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Adriamycin pfs and have Tooth abscess?
Check whether Tooth abscess is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Tooth abscess and when was it recovered:
Expand to all the drugs that have ingredients of doxorubicin hydrochloride:
Alternative drugs to, pros and cons of Adriamycin pfs:
- Adriamycin pfs (6,495 reports)
Common Adriamycin pfs side effects:
- Pain: 852 reports
- Fever: 824 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 715 reports
- Breathing difficulty: 651 reports
- Stress and anxiety: 618 reports
- Pneumonia: 611 reports
Browse all side effects of Adriamycin pfs:
a b c d e f g h i j k l m n o p q r s t u v w x y zTooth abscess treatments and more:
- Tooth abscess (31,296 reports)
COVID vaccines that are related to Tooth abscess:
- Tooth abscess in Moderna COVID Vaccine
- Tooth abscess in Pfizer BioNTech Covid Vaccine
- Tooth abscess in Johnson and Johnson Covid Vaccine
Common drugs associated with Tooth abscess:
- Prednisone: 2,896 reports
- Fosamax: 2,757 reports
- Enbrel: 2,720 reports
- Methotrexate: 2,561 reports
- Zometa: 2,488 reports
- Humira: 2,250 reports
- Aspirin: 1,510 reports
- Aredia: 1,327 reports
- Synthroid: 1,093 reports
- Celebrex: 993 reports
All the drugs that are associated with Tooth abscess:
- Tooth abscess (2,420 drugs)
Common conditions associated with Tooth abscess:
- Rheumatoid arthritis: 4,767 reports
- Osteoporosis: 2,598 reports
- Psoriasis: 1,292 reports
- Multiple myeloma: 1,254 reports
- Multiple sclerosis: 1,230 reports
- Crohn's disease: 1,155 reports
- High blood pressure: 1,133 reports
All the conditions that are associated with Tooth abscess:
- Tooth abscess (1,597 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Adriamycin pfs) and Adriamycin pfs (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lexapro and Ligament Sprain - 4 seconds ago
- Lidex and Joint Contracture - 5 seconds ago
- Hair Loss and drugs of ingredients of chromium - 6 seconds ago
- Lidex and Failure To Thrive - 6 seconds ago
- Viagra and Lyme Disease - 8 seconds ago
- Lexxel and Weight Increased - 12 seconds ago
- Cisplatin and Prothrombin Time Abnormal - 13 seconds ago
- Hydroxyzine Hydrochloride vs. Doxepin Hydrochloride - 14 seconds ago
- Mevacor and Pancreatitis - 15 seconds ago
- Everolimus and Female Genital Tract Fistula - 19 seconds ago